109 related articles for article (PubMed ID: 18364203)
21. Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma.
Choi JY; Cho SI; Do NY; Kang CY; Lim SC
J Otolaryngol Head Neck Surg; 2010 Feb; 39(1):28-34. PubMed ID: 20122341
[TBL] [Abstract][Full Text] [Related]
22. [Molecular prognostic markers of lymphogenous metastasis of squamous cell carcinoma of the larynx (an immuno-histochemical study)].
Kulagin RN
Vestn Otorinolaringol; 2011; (5):11-4. PubMed ID: 22334915
[TBL] [Abstract][Full Text] [Related]
23. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
[TBL] [Abstract][Full Text] [Related]
24. Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patients with squamous cell head and neck cancer: eight cases with a review of the literature.
Resta L; Piscitelli D; Fiore MG; Di Nicola V; Fiorella ML; Altavilla A; Marzullo A
Eur Arch Otorhinolaryngol; 2004 Oct; 261(9):473-8. PubMed ID: 15546174
[TBL] [Abstract][Full Text] [Related]
25. [The problem of hidden metastases in larynx and hypopharynx carcinoma].
Sieczka J; Zietek E
Otolaryngol Pol; 2000; 54 Suppl 31():267-9. PubMed ID: 10974903
[TBL] [Abstract][Full Text] [Related]
26. Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification.
Alonso Guervós M; Alvarez Marcos C; Llorente JL; Sampedro Nuño A; Suárez C; Hermsen M
Oral Oncol; 2009 Jul; 45(7):600-4. PubMed ID: 18952489
[TBL] [Abstract][Full Text] [Related]
27. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases.
Andrews NA; Jones AS; Helliwell TR; Kinsella AR
Br J Cancer; 1997; 75(10):1474-80. PubMed ID: 9166940
[TBL] [Abstract][Full Text] [Related]
28. [The difference of larynx cancer stage evaluation between clinical and pathological examinations].
Wolny E; Idasiak A; Wydmański J; Miszczyk L
Otolaryngol Pol; 2006; 60(1):15-20. PubMed ID: 16821535
[TBL] [Abstract][Full Text] [Related]
29. [Patterns and prognostic factors of cervical lymph node metastasis in supraglottic laryngeal carcinoma].
Li X; Di B; Shao Y; Shang Y; Cheng J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):707-10. PubMed ID: 15831037
[TBL] [Abstract][Full Text] [Related]
30. [Significance of p16 and C-myc expression in the laryngeal squamous cell carcinoma].
Peng J; Zeng Y; Xu Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 11(8):352-5. PubMed ID: 10323033
[TBL] [Abstract][Full Text] [Related]
31. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
Dong P; Li X; Yu Z; Lu G
J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
[TBL] [Abstract][Full Text] [Related]
32. Relationship of E-cadherin with cervical lymph node metastasis in laryngeal cancer.
Zvrko E; Mikić A; Jancić S
Coll Antropol; 2012 Nov; 36 Suppl 2():119-24. PubMed ID: 23397769
[TBL] [Abstract][Full Text] [Related]
33. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.
Takes RP; Baatenburg de Jong RJ; Wijffels K; Schuuring E; Litvinov SV; Hermans J; van Krieken JH
J Pathol; 2001 Jul; 194(3):298-302. PubMed ID: 11439361
[TBL] [Abstract][Full Text] [Related]
34. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
35. Level IIB lymph node metastasis in laryngeal and hypopharyngeal squamous cell carcinoma: single-institution case series and review of the literature.
Gross BC; Olsen SM; Lewis JE; Kasperbauer JL; Moore EJ; Olsen KD; Price DL
Laryngoscope; 2013 Dec; 123(12):3032-6. PubMed ID: 23686866
[TBL] [Abstract][Full Text] [Related]
36. [Expression and function of laminin receptor in laryngeal squamous cell carcinoma].
Xie M; Zhou L; Zhou JQ; Tao L
Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):539-42. PubMed ID: 15555284
[TBL] [Abstract][Full Text] [Related]
37. Low phosphorylated AKT expression in laryngeal cancer: indications for a higher metastatic risk.
Nijkamp MM; Span PN; Stegeman H; Grénman R; Kaanders JH; Bussink J
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):349-55. PubMed ID: 23886414
[TBL] [Abstract][Full Text] [Related]
38. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
39. [The expressions of Ki67 and VEGF in squamous cell carcinoma of larynx and the correlation between the two marks].
Sun D; Wang Y; Kong W; Liu B; Chen X; Zhang D; Zhang S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 18(2):93-6. PubMed ID: 15362686
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Xie M; Sun Y; Li Y
Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
